)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Livzon Pharmaceutical
Livzon Pharmaceutical (000513) investor relations material
Livzon Pharmaceutical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary26 Oct, 2026
Executive summary
Q3 2026 revenue fell 18.44% YoY to RMB2.320bn; net profit attributable to shareholders declined 24.76% to RMB355.9m. YTD revenue and attributable net profit fell 19.71% and 26.57%, respectively.
YTD operating cash flow remained strong at RMB2.492bn, down 1.33% YoY.
Financial highlights
Q3 revenue was RMB2.320bn, down 18.44% YoY; YTD revenue was RMB7.319bn, down 19.71%.
Q3 net profit attributable to shareholders was RMB355.9m, down 24.76%; YTD was RMB1.288bn, down 26.57%.
Excluding non-recurring items, attributable net profit was RMB370.2m in Q3, down 18.39% YoY, and RMB1.260bn YTD, down 26.38%.
YTD operating profit was RMB1.843bn versus RMB2.511bn; net profit was RMB1.552bn versus RMB2.130bn.
Key financial ratios and metrics
Basic and diluted EPS were RMB0.40 in Q3, down 23.08% YoY; YTD EPS was RMB1.45, down 26.02%.
Weighted average ROE was 2.61% for Q3, down 0.8 percentage points, and 9.22% YTD, down 3.27 percentage points.
Period-end total assets were RMB23.246bn, down 3.08% from year-end; equity attributable to shareholders was RMB13.019bn, down 6.26%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Livzon Pharmaceutical
- Revenue and profit fell, but cash flow and global expansion remained robust.000513
Q2 2026 - Q1 2026 saw lower revenue and profit but stronger cash flow and ongoing innovation momentum.000513Q1 2026
- 2025 revenue up 1.76%, adjusted net profit up 1.51%, and overseas sales rose 11.97%.000513Q4 2025
- Q3 2025 saw modest revenue growth, a dip in net profit, and robust operating cash flow.000513Q3 2025
- Net profit rose 9.40% to RMB 1.28 billion on stable revenue and strong overseas growth.000513Q2 2025
- Net profit rose 4.44% year-over-year to RMB 1.67 billion, despite a 5.94% revenue drop.000513Q3 2024
- Net profit grew 3.21% to RMB 1.17 billion despite a 6.09% revenue decline.000513Q2 2024
- Net profit up 4.75% year-over-year, revenue down 1.92%, with major share buybacks.000513Q1 2025
- Net profit grew 5.5% to RMB 2.06B despite a 4.97% revenue drop, with higher dividend proposed.000513Q4 2024
Next Livzon Pharmaceutical earnings date
Q4 202626 Mar, 2027
Livzon Pharmaceutical
Next Livzon Pharmaceutical earnings date
Q4 202626 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)